Terumo BCT's Grant

Terumo BCT raised a round of funding on June 22, 2016. Investors include Biomedical Advanced Research and Development Authority.

Terumo BCT, a global provider in blood component, therapeutic apheresis and cellular technologies, offers a combination of apheresis collections, manual and automated whole blood processing, and patho…

Articles about Terumo BCT's Grant: